S. Watson

发表

The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.

Paul W Smith, I. Forbes, P. Wyman, 2010, Bioorganic & medicinal chemistry letters.

Identification of a sulfonamide series of CCR2 antagonists.

Carl A. Brooks, V. Piercy, R. Ife, 2010, Bioorganic & medicinal chemistry letters.

In vivo activity of an azole series of CCR2 antagonists.

Carl A. Brooks, V. Piercy, P. Gough, 2012, Bioorganic & medicinal chemistry letters.

The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.

Roseanne Norris, D. Montanari, Ashley A. Barnes, 2009, Bioorganic & medicinal chemistry letters.

Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor.

A. Goetz, A. Peat, D. M. Hickey, 2007, Bioorganic & medicinal chemistry letters.

The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.

Ian Holmes, Simon Gaines, M. Convery, 2009, Bioorganic & medicinal chemistry letters.

Direct Inhibition of Cyclooxygenase-1 and -2 by the Kinase Inhibitors SB 203580 and PD 98059

S. Watson, S. Pasquet, A. Börsch-Haubold, 1998, The Journal of Biological Chemistry.

Identification of the Phosphorylation Sites of Cytosolic Phospholipase A2 in Agonist-stimulated Human Platelets and HeLa Cells*

M. Gelb, R. Kramer, S. Watson, 1998, The Journal of Biological Chemistry.

C-linked pyrazole biaryl tetrazoles as antagonists of angiotensin II Part II: pharmacokinetics and an efficient regioselective synthesis

A. W. Dean, M. Bayliss, S. Watson, 1994 .

Characterisation of inverse agonism of the orphan-G protein-coupled receptor GPR52 by cannabinoid ligands Cannabidiol and O-1918

Alicia P. Higueruelo, Flavia Autore, M. O’Brien, 2021, Heliyon.

The characterization of a novel V1b antagonist lead series.

G. Burton, A. Green, S. Watson, 2011, Bioorganic & medicinal chemistry letters.

The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.

J. Willis, D. Montanari, Ashley A. Barnes, 2010, Bioorganic & medicinal chemistry letters.

Application of high-throughput screening techniques to drug discovery.

B Cox, J C Denyer, A Binnie, 2000 .

TEMPORARY REMOVAL: Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug design.

S. P. Andrews, M. Congreve, J. Mason, 2019, Bioorganic & medicinal chemistry letters.

The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.

J. Willis, D. Montanari, Ashley A. Barnes, 2010, Bioorganic & medicinal chemistry letters.

Benzofuran based angiotensin II antagonists related to GR117289: enhancement of potency in vitro and oral activity

J. Montana, K. Clark, M. J. Robertson, 1993 .